BC Cancer Agency Pioneers Faster, More Precise Radiotherapy

BC Cancer Agency Pioneers Faster, More Precise Radiotherapy
MSN MoneyCentral – Clinicians complete a prostate cancer treatment in less than two minutes using volumetric arc therapy (VMAT) with technology from Varian Medical Systems VANCOUVER, British Columbia, Nov. 9 /PRNewswire-FirstCall/ — Clinicians at BC Cancer Agency have
Source: news.moneycentral.msn.com

Starting Gate: Clinton Opponents Latch Onto Credibility Issue
CBS News – leveled at the comparison, including from the American Cancer Society, Giuliani replied, “even if you want to quibble about the statistics, you find me the person who leaves the United States and goes to England for prostate cancer treatment, and I’d
Source: www.cbsnews.com

Patients get state-of-the-art cancer treatment at nearby Edwards
Summit Daily News – A patient lies down as the radiation therapy machine is prepared for his prostate cancer treatment at the Shaw Regional Cancer Center in Edwards. The center recently received top honors from a national cancer commission. Kristin Anderson/kanderson
Source: www.summitdaily.com

Under 50s not invited: Saga launches networking site for silver
Daily Mail – The most popular topics of discussion on the site are petitions to the Government about disability benefits, prostate cancer treatment and pensions. But the health forum has an also proved popular, with daily debates and advice about cholesterol
Source: www.dailymail.co.uk

Surgery Best For Prostate Cancer Compared To Radiation Or Hormone
Best Syndication – Prostate cancer treatment options include surgery, radiation therapy, hormonal therapy, chemotherapy, proton therapy, and sometimes a combination of therapies. Doctors will sometimes consider the patients age before advising a treatment option
Source: www.bestsyndication.com

Google reveals its much anticipated cell-phone plans, no ”gPhone
San Jose Mercury News – Deaths halt drug test: South San Francisco-based Novacea lost more than half its value on the Nasdaq stock market after it halted testing of its prostate-cancer treatment in order to analyze “an imbalance of deaths.” Novacea’s shares fell $4.30 to $2
Source: www.mercurynews.com